Nektar Therapeutics (NKTR) CEO Howard Robin on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/29/20
Nektar Therapeutics (NKTR) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 02/06/20
How An FDA Committee Pulled The Rug Out From This Highflying BiotechInvestors Business Daily • 01/15/20
Stocks making the biggest moves after the bell: Nektar Therapeutics, Beyond Meat and CriteoCNBC • 01/14/20
Nektar Therapeutics: Updates To Thesis, Bempeg To Boost Opdivo Prospects In Crowded I-O ArenaSeeking Alpha • 01/14/20
Why Bristol's Vote Of Confidence Sent This Biotech Stock RocketingInvestors Business Daily • 01/10/20